Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Change in Receivables of -$971000.0 for Q1 2026, down 211.61% sequentially from $870000.0 in Q4 2025, and down 150.39% YoY from $1.9 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Change in Receivables (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Change in Receivables for 7 years, with the latest figure at -$971000.0 in Q1 2026.
- Quarterly Change in Receivables fell 150.39% year-over-year to -$971000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.4 million (down 200.12% YoY) and the FY2025 annual result came in at -$485000.0, down 142.96% from the prior year.
- Change in Receivables declined to -$971000.0 in Q1 2026 per IMDX's latest filing, from $870000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.9 million in Q1 2025 and troughed at -$3.0 million in Q2 2025.
- A 5-year average of $8176.5 and a median of $21000.0 in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables surged 6585.71% in 2024, then sank 3884.21% in 2025.
- Over 5 years, Change in Receivables stood at $22000.0 in 2022, then decreased by 4.55% to $21000.0 in 2023, then soared by 6585.71% to $1.4 million in 2024, then plunged by 38.03% to $870000.0 in 2025, then tumbled by 211.61% to -$971000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$971000.0, $870000.0, and -$254000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -71.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 4.37 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -12.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.04 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 26.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 25.09 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 59.20 Mn |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35,000.00 |
| Jun 30, 2026 | 35,000.00 |
| Mar 31, 2026 | -971,000.00 |
| Mar 31, 2026 | -971,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Sep 30, 2025 | -254,000.00 |
| Jun 30, 2025 | -3.03 Mn |
| Jun 30, 2025 | -3.03 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 124,000.00 |
| Sep 30, 2024 | 124,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Jun 30, 2024 | -76,000.00 |
| Mar 31, 2024 | -323,000.00 |
| Mar 31, 2024 | -323,000.00 |